C4 Therapeutics, Inc.
CEREBLON BINDERS FOR THE DEGRADATION OF IKAROS
Last updated:
Abstract:
The present invention provides cereblon binders for the degradation of Ikaros or Aiolos by the ubiquitin proteasome pathway along with their use in therapeutic applications as described herein.
Status:
Application
Type:
Utility
Filling date:
24 Sep 2020
Issue date:
14 Jan 2021